메뉴 건너뛰기




Volumn 37, Issue 2, 2016, Pages 2321-2331

Protective autophagy promotes the resistance of HER2-positive breast cancer cells to lapatinib

Author keywords

Autophagy; Breast cancer; Lapatinib; Resistance

Indexed keywords

ADENYLATE KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; LAPATINIB; MAMMALIAN TARGET OF RAPAMYCIN; ANTINEOPLASTIC AGENT; ERBB2 PROTEIN, HUMAN; QUINAZOLINE DERIVATIVE;

EID: 84941662473     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-3800-9     Document Type: Article
Times cited : (37)

References (30)
  • 2
    • 78149478929 scopus 로고    scopus 로고
    • What do we learn from HER2-positive breast cancer genomic profiles?
    • PID: 20519027
    • Theillet C. What do we learn from HER2-positive breast cancer genomic profiles? Breast Cancer Res. 2010;12:107.
    • (2010) Breast Cancer Res , vol.12 , pp. 107
    • Theillet, C.1
  • 3
    • 84903751985 scopus 로고    scopus 로고
    • Acquired PIK3CA amplification causes resistance to selective phosphoinositide 3-kinase inhibitors in breast cancer
    • COI: 1:CAS:528:DC%2BC2cXlsFSl, PID: 24366379
    • Huw LY, O'Brien C, Pandita A, Mohan S, Spoerke JM, Lu S, et al. Acquired PIK3CA amplification causes resistance to selective phosphoinositide 3-kinase inhibitors in breast cancer. Oncogenesis. 2013;2:e83.
    • (2013) Oncogenesis , vol.2 , pp. e83
    • Huw, L.Y.1    O'Brien, C.2    Pandita, A.3    Mohan, S.4    Spoerke, J.M.5    Lu, S.6
  • 4
    • 84901696572 scopus 로고    scopus 로고
    • Prognostic and biological significance of proliferation and HER2 expression in the luminal class of breast cancer
    • COI: 1:CAS:528:DC%2BC2cXmsV2mt7w%3D, PID: 24744091
    • Jerjees DA, Alabdullah M, Green AR, Alshareeda A, Macmillan RD, Ellis IO, et al. Prognostic and biological significance of proliferation and HER2 expression in the luminal class of breast cancer. Breast Cancer Res Treat. 2014;145:317–30.
    • (2014) Breast Cancer Res Treat , vol.145 , pp. 317-330
    • Jerjees, D.A.1    Alabdullah, M.2    Green, A.R.3    Alshareeda, A.4    Macmillan, R.D.5    Ellis, I.O.6
  • 5
    • 84900514556 scopus 로고    scopus 로고
    • Survival of HER2-positive primary breast cancer patients treated by neoadjuvant chemotherapy plus trastuzumab: a multicenter retrospective observational study (JBCRG-C03 study)
    • COI: 1:CAS:528:DC%2BC2cXltl2it78%3D, PID: 24682674
    • Takada M, Ishiguro H, Nagai S, Ohtani S, Kawabata H, Yanagita Y, et al. Survival of HER2-positive primary breast cancer patients treated by neoadjuvant chemotherapy plus trastuzumab: a multicenter retrospective observational study (JBCRG-C03 study). Breast Cancer Res Treat. 2014;145:143–53.
    • (2014) Breast Cancer Res Treat , vol.145 , pp. 143-153
    • Takada, M.1    Ishiguro, H.2    Nagai, S.3    Ohtani, S.4    Kawabata, H.5    Yanagita, Y.6
  • 6
    • 84866552915 scopus 로고    scopus 로고
    • Lapatinib, trastuzumab or the combination added to preoperative chemotherapy for breast cancer: a meta-analysis of randomized evidence
    • COI: 1:CAS:528:DC%2BC38XhtlGmsbnK, PID: 22875745
    • Valachis A, Nearchou A, Lind P, Mauri D. Lapatinib, trastuzumab or the combination added to preoperative chemotherapy for breast cancer: a meta-analysis of randomized evidence. Breast Cancer Res Treat. 2012;135:655–62.
    • (2012) Breast Cancer Res Treat , vol.135 , pp. 655-662
    • Valachis, A.1    Nearchou, A.2    Lind, P.3    Mauri, D.4
  • 7
    • 34948845576 scopus 로고    scopus 로고
    • Lapatinib in the treatment of breast cancer
    • COI: 1:CAS:528:DC%2BD2sXhtVOgtLnK, PID: 17892419
    • Higa GM, Abraham J. Lapatinib in the treatment of breast cancer. Expert Rev Anticancer Ther. 2007;7:1183–92.
    • (2007) Expert Rev Anticancer Ther , vol.7 , pp. 1183-1192
    • Higa, G.M.1    Abraham, J.2
  • 8
    • 33845886440 scopus 로고    scopus 로고
    • Lapatinib plus capecitabine for HER2-positive advanced breast cancer
    • COI: 1:CAS:528:DC%2BD2sXhslSqsA%3D%3D, PID: 17192538
    • Geyer CE, Forster J, Lindquist D, Chan S, Romieu CG, Pienkowski T, et al. Lapatinib plus capecitabine for HER2-positive advanced breast cancer. N Engl J Med. 2006;355:2733–43.
    • (2006) N Engl J Med , vol.355 , pp. 2733-2743
    • Geyer, C.E.1    Forster, J.2    Lindquist, D.3    Chan, S.4    Romieu, C.G.5    Pienkowski, T.6
  • 9
    • 63149110733 scopus 로고    scopus 로고
    • Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer
    • COI: 1:CAS:528:DC%2BD1MXitVOktLo%3D, PID: 19228746
    • Lin NU, Dieras V, Paul D, Lossignol D, Christodoulou C, Stemmler HJ, et al. Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer. Clin Cancer Res. 2009;15:1452–9.
    • (2009) Clin Cancer Res , vol.15 , pp. 1452-1459
    • Lin, N.U.1    Dieras, V.2    Paul, D.3    Lossignol, D.4    Christodoulou, C.5    Stemmler, H.J.6
  • 11
    • 46449113024 scopus 로고    scopus 로고
    • Efficacy and safety of lapatinib as first-line therapy for ErbB2-amplified locally advanced or metastatic breast cancer
    • COI: 1:CAS:528:DC%2BD1cXoslOqsLo%3D, PID: 18458039
    • Gomez HL, Doval DC, Chavez MA, Ang PC, Aziz Z, Nag S, et al. Efficacy and safety of lapatinib as first-line therapy for ErbB2-amplified locally advanced or metastatic breast cancer. J Clin Oncol. 2008;26:2999–3005.
    • (2008) J Clin Oncol , vol.26 , pp. 2999-3005
    • Gomez, H.L.1    Doval, D.C.2    Chavez, M.A.3    Ang, P.C.4    Aziz, Z.5    Nag, S.6
  • 12
    • 70149109569 scopus 로고    scopus 로고
    • Novel mechanism of lapatinib resistance in HER2-positive breast tumor cells: activation of AXL
    • COI: 1:CAS:528:DC%2BD1MXhtVOmtL%2FO, PID: 19671800
    • Liu L, Greger J, Shi H, Liu Y, Greshock J, Annan R, et al. Novel mechanism of lapatinib resistance in HER2-positive breast tumor cells: activation of AXL. Cancer Res. 2009;69:6871–8.
    • (2009) Cancer Res , vol.69 , pp. 6871-6878
    • Liu, L.1    Greger, J.2    Shi, H.3    Liu, Y.4    Greshock, J.5    Annan, R.6
  • 13
    • 84883793323 scopus 로고    scopus 로고
    • RON confers lapatinib resistance in HER2-positive breast cancer cells
    • COI: 1:CAS:528:DC%2BC3sXhtFSmtrfK, PID: 23811285
    • Wang Q, Quan H, Zhao J, Xie C, Wang L, Lou L. RON confers lapatinib resistance in HER2-positive breast cancer cells. Cancer Lett. 2013;340:43–50.
    • (2013) Cancer Lett , vol.340 , pp. 43-50
    • Wang, Q.1    Quan, H.2    Zhao, J.3    Xie, C.4    Wang, L.5    Lou, L.6
  • 14
    • 84859377144 scopus 로고    scopus 로고
    • MET activation mediates resistance to lapatinib inhibition of HER2-amplified gastric cancer cells
    • COI: 1:CAS:528:DC%2BC38XjtlKisrs%3D, PID: 22238368
    • Chen CT, Kim H, Liska D, Gao S, Christensen JG, Weiser MR. MET activation mediates resistance to lapatinib inhibition of HER2-amplified gastric cancer cells. Mol Cancer Ther. 2012;11:660–9.
    • (2012) Mol Cancer Ther , vol.11 , pp. 660-669
    • Chen, C.T.1    Kim, H.2    Liska, D.3    Gao, S.4    Christensen, J.G.5    Weiser, M.R.6
  • 15
    • 84902116278 scopus 로고    scopus 로고
    • Epidermal growth factor-receptor activation modulates Src-dependent resistance to lapatinib in breast cancer models
    • PID: 24887236
    • Formisano L, Nappi L, Rosa R, Marciano R, D'Amato C, D'Amato V, et al. Epidermal growth factor-receptor activation modulates Src-dependent resistance to lapatinib in breast cancer models. Breast Cancer Res. 2014;16:R45.
    • (2014) Breast Cancer Res , vol.16 , pp. R45
    • Formisano, L.1    Nappi, L.2    Rosa, R.3    Marciano, R.4    D'Amato, C.5    D'Amato, V.6
  • 16
    • 84892566293 scopus 로고    scopus 로고
    • Enhanced PI3K p110alpha signaling confers acquired lapatinib resistance that can be effectively reversed by a p110alpha-selective PI3K inhibitor
    • COI: 1:CAS:528:DC%2BC2cXnsFSrtg%3D%3D, PID: 24249715
    • Brady SW, Zhang J, Seok D, Wang H, Yu D. Enhanced PI3K p110alpha signaling confers acquired lapatinib resistance that can be effectively reversed by a p110alpha-selective PI3K inhibitor. Mol Cancer Ther. 2014;13:60–70.
    • (2014) Mol Cancer Ther , vol.13 , pp. 60-70
    • Brady, S.W.1    Zhang, J.2    Seok, D.3    Wang, H.4    Yu, D.5
  • 17
    • 56549116658 scopus 로고    scopus 로고
    • Macroautophagy inhibition sensitizes tamoxifen-resistant breast cancer cells and enhances mitochondrial depolarization
    • COI: 1:CAS:528:DC%2BD1cXhtl2mu7nO, PID: 18172760
    • Qadir MA, Kwok B, Dragowska WH, To KH, Le D, Bally MB, et al. Macroautophagy inhibition sensitizes tamoxifen-resistant breast cancer cells and enhances mitochondrial depolarization. Breast Cancer Res Treat. 2008;112:389–403.
    • (2008) Breast Cancer Res Treat , vol.112 , pp. 389-403
    • Qadir, M.A.1    Kwok, B.2    Dragowska, W.H.3    To, K.H.4    Le, D.5    Bally, M.B.6
  • 19
    • 84887437596 scopus 로고    scopus 로고
    • Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment
    • COI: 1:CAS:528:DC%2BC3sXhs1SksbjL, PID: 24113172
    • Sui X, Chen R, Wang Z, Huang Z, Kong N, Zhang M, et al. Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis. 2013;4:e838.
    • (2013) Cell Death Dis , vol.4 , pp. e838
    • Sui, X.1    Chen, R.2    Wang, Z.3    Huang, Z.4    Kong, N.5    Zhang, M.6
  • 20
    • 84883363937 scopus 로고    scopus 로고
    • Autophagy stimulates apoptosis in HER2-overexpressing breast cancers treated by lapatinib
    • COI: 1:CAS:528:DC%2BC3sXhs1WgtbrN, PID: 23794518
    • Zhu X, Wu L, Qiao H, Han T, Chen S, Liu X, et al. Autophagy stimulates apoptosis in HER2-overexpressing breast cancers treated by lapatinib. J Cell Biochem. 2013;114:2643–53.
    • (2013) J Cell Biochem , vol.114 , pp. 2643-2653
    • Zhu, X.1    Wu, L.2    Qiao, H.3    Han, T.4    Chen, S.5    Liu, X.6
  • 21
    • 80052381384 scopus 로고    scopus 로고
    • Seeing is believing: the impact of electron microscopy on autophagy research
    • COI: 1:CAS:528:DC%2BC38Xhs1Oqsb0%3D, PID: 21566462
    • Eskelinen EL, Reggiori F, Baba M, Kovacs AL, Seglen PO. Seeing is believing: the impact of electron microscopy on autophagy research. Autophagy. 2011;7:935–56.
    • (2011) Autophagy , vol.7 , pp. 935-956
    • Eskelinen, E.L.1    Reggiori, F.2    Baba, M.3    Kovacs, A.L.4    Seglen, P.O.5
  • 22
    • 34250900953 scopus 로고    scopus 로고
    • LC3, an autophagosome marker, can be incorporated into protein aggregates independent of autophagy: caution in the interpretation of LC3 localization
    • COI: 1:CAS:528:DC%2BD2sXhtVGrtLbO, PID: 17387262
    • Kuma A, Matsui M, Mizushima N. LC3, an autophagosome marker, can be incorporated into protein aggregates independent of autophagy: caution in the interpretation of LC3 localization. Autophagy. 2007;3:323–8.
    • (2007) Autophagy , vol.3 , pp. 323-328
    • Kuma, A.1    Matsui, M.2    Mizushima, N.3
  • 23
    • 84886721495 scopus 로고    scopus 로고
    • Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial
    • COI: 1:CAS:528:DC%2BC3sXhsFOiu73K, PID: 24095300
    • Robidoux A, Tang G, Rastogi P, Geyer Jr CE, Azar CA, Atkins JN, et al. Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial. Lancet Oncol. 2013;14:1183–92.
    • (2013) Lancet Oncol , vol.14 , pp. 1183-1192
    • Robidoux, A.1    Tang, G.2    Rastogi, P.3    Geyer, C.E.4    Azar, C.A.5    Atkins, J.N.6
  • 24
    • 84892611820 scopus 로고    scopus 로고
    • Src and CXCR4 are involved in the invasiveness of breast cancer cells with acquired resistance to lapatinib
    • PID: 24200972
    • De Luca A, D'Alessio A, Gallo M, Maiello MR, Bode AM, Normanno N. Src and CXCR4 are involved in the invasiveness of breast cancer cells with acquired resistance to lapatinib. Cell Cycle. 2014;13:148–56.
    • (2014) Cell Cycle , vol.13 , pp. 148-156
    • De Luca, A.1    D'Alessio, A.2    Gallo, M.3    Maiello, M.R.4    Bode, A.M.5    Normanno, N.6
  • 25
    • 84907184381 scopus 로고    scopus 로고
    • Silencing of EEF2K (eukaryotic elongation factor-2 kinase) reveals AMPK-ULK1-dependent autophagy in colon cancer cells
    • Xie CM, Liu XY, Sham KW, Lai JM, Cheng CH. Silencing of EEF2K (eukaryotic elongation factor-2 kinase) reveals AMPK-ULK1-dependent autophagy in colon cancer cells. Autophagy 2014;10.
    • (2014) Autophagy , pp. 10
    • Xie, C.M.1    Liu, X.Y.2    Sham, K.W.3    Lai, J.M.4    Cheng, C.H.5
  • 26
    • 84872036691 scopus 로고    scopus 로고
    • Structure of the human ATG12∼ATG5 conjugate required for LC3 lipidation in autophagy
    • COI: 1:CAS:528:DC%2BC38XhslGktbrO, PID: 23202584
    • Otomo C, Metlagel Z, Takaesu G, Otomo T. Structure of the human ATG12∼ATG5 conjugate required for LC3 lipidation in autophagy. Nat Struct Mol Biol. 2013;20:59–66.
    • (2013) Nat Struct Mol Biol , vol.20 , pp. 59-66
    • Otomo, C.1    Metlagel, Z.2    Takaesu, G.3    Otomo, T.4
  • 27
    • 84870601009 scopus 로고    scopus 로고
    • Selective autophagy degrades DICER and AGO2 and regulates miRNA activity
    • COI: 1:CAS:528:DC%2BC38Xhs1CktLjF, PID: 23143396
    • Gibbings D, Mostowy S, Jay F, Schwab Y, Cossart P, Voinnet O. Selective autophagy degrades DICER and AGO2 and regulates miRNA activity. Nat Cell Biol. 2012;14:1314–21.
    • (2012) Nat Cell Biol , vol.14 , pp. 1314-1321
    • Gibbings, D.1    Mostowy, S.2    Jay, F.3    Schwab, Y.4    Cossart, P.5    Voinnet, O.6
  • 28
    • 84859404834 scopus 로고    scopus 로고
    • miRNA-130a targets ATG2B and DICER1 to inhibit autophagy and trigger killing of chronic lymphocytic leukemia cells
    • COI: 1:CAS:528:DC%2BC38XkvVelsb0%3D, PID: 22350415
    • Kovaleva V, Mora R, Park YJ, Plass C, Chiramel AI, Bartenschlager R, et al. miRNA-130a targets ATG2B and DICER1 to inhibit autophagy and trigger killing of chronic lymphocytic leukemia cells. Cancer Res. 2012;72:1763–72.
    • (2012) Cancer Res , vol.72 , pp. 1763-1772
    • Kovaleva, V.1    Mora, R.2    Park, Y.J.3    Plass, C.4    Chiramel, A.I.5    Bartenschlager, R.6
  • 29
    • 84923355230 scopus 로고    scopus 로고
    • The essential role of TNIK gene amplification in gastric cancer growth
    • COI: 1:CAS:528:DC%2BC2cXjtVKjtro%3D, PID: 24566388
    • Yu DH, Zhang X, Wang H, Zhang L, Chen H, Hu M, et al. The essential role of TNIK gene amplification in gastric cancer growth. Oncogenesis. 2014;2:e89.
    • (2014) Oncogenesis , vol.2 , pp. e89
    • Yu, D.H.1    Zhang, X.2    Wang, H.3    Zhang, L.4    Chen, H.5    Hu, M.6
  • 30
    • 33745859721 scopus 로고    scopus 로고
    • Autophagy, bafilomycin and cell death: the “a-B-cs” of plecomacrolide-induced neuroprotection
    • COI: 1:CAS:528:DC%2BD28XnsVWjtr8%3D, PID: 16874105
    • Shacka JJ, Klocke BJ, Roth KA. Autophagy, bafilomycin and cell death: the “a-B-cs” of plecomacrolide-induced neuroprotection. Autophagy. 2006;2:228–30.
    • (2006) Autophagy , vol.2 , pp. 228-230
    • Shacka, J.J.1    Klocke, B.J.2    Roth, K.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.